61 related articles for article (PubMed ID: 22545323)
1. Sometimes it takes darkness to see the light: pitfalls in the interpretation of cell proliferation markers (Ki-67 and PCNA).
Castilla C; McDonough P; Tumer G; Lambert PC; Lambert WC
Skinmed; 2012; 10(2):90-2. PubMed ID: 22545323
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors.
Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
[TBL] [Abstract][Full Text] [Related]
4. Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders.
Gambichler T; Bischoff S; Bechara FG; Altmeyer P; Kreuter A
J Dermatol Sci; 2008 Feb; 49(2):125-32. PubMed ID: 17826963
[TBL] [Abstract][Full Text] [Related]
5. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
[TBL] [Abstract][Full Text] [Related]
7. Morphological evaluation of parathyroid adenomas and immunohistochemical analysis of PCNA and Ki-67 proliferation markers.
Demıralay E; Altaca G; Demırhan B
Turk Patoloji Derg; 2011; 27(3):215-20. PubMed ID: 21935871
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study.
Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A
Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728
[TBL] [Abstract][Full Text] [Related]
10. Expression of Ki-67 and PCNA as proliferating markers in prostate cancer.
Sulik M; Guzińska-Ustymowicz K
Rocz Akad Med Bialymst; 2002; 47():262-9. PubMed ID: 12533969
[TBL] [Abstract][Full Text] [Related]
11. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
[TBL] [Abstract][Full Text] [Related]
12. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
13. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
Steck K; el-Naggar AK
Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
15. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
16. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa.
Bromley M; Rew D; Becciolini A; Balzi M; Chadwick C; Hewitt D; Li YQ; Potten CS
Eur J Histochem; 1996; 40(2):89-100. PubMed ID: 8839702
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers.
Czyzewska J; Guzińska-Ustymowicz K; Lebelt A; Zalewski B; Kemona A
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():64-6. PubMed ID: 15638377
[TBL] [Abstract][Full Text] [Related]
18. Expression of proliferating cell nuclear antigen (PCNA): proliferative phase functions and malignant transformation of melanocytes.
Iyengar B
Melanoma Res; 1994 Oct; 4(5):293-5. PubMed ID: 7858412
[TBL] [Abstract][Full Text] [Related]
19. Effect of RNAi-mediated LRIG3 gene silencing on proliferation of glioma GL15 cells and expression of PCNA and Ki-67.
Cai MJ; Xie RF; Han L; Chen RD; Wang BF; Ye F; Guo DS; Lei T
Ai Zheng; 2009 Jan; 28(1):1-4. PubMed ID: 19448407
[TBL] [Abstract][Full Text] [Related]
20. Effects of ultraviolet B exposure on the expression of proliferating cell nuclear antigen in murine skin.
Moore JO; Palep SR; Saladi RN; Gao D; Wang Y; Phelps RG; Lebwohl MG; Wei H
Photochem Photobiol; 2004; 80(3):587-95. PubMed ID: 15623348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]